188 related articles for article (PubMed ID: 18780829)
1. Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosis.
Wilson C; Purcell C; Seaton A; Oladipo O; Maxwell PJ; O'Sullivan JM; Wilson RH; Johnston PG; Waugh DJ
J Pharmacol Exp Ther; 2008 Dec; 327(3):746-59. PubMed ID: 18780829
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of constitutive and cxc-chemokine-induced NF-kappaB activity potentiates ansamycin-based HSP90-inhibitor cytotoxicity in castrate-resistant prostate cancer cells.
Seaton A; Maxwell PJ; Hill A; Gallagher R; Pettigrew J; Wilson RH; Waugh DJ
Br J Cancer; 2009 Nov; 101(9):1620-9. PubMed ID: 19809428
[TBL] [Abstract][Full Text] [Related]
3. Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway.
Ruiz de Porras V; Bystrup S; Martínez-Cardús A; Pluvinet R; Sumoy L; Howells L; James MI; Iwuji C; Manzano JL; Layos L; Bugés C; Abad A; Martínez-Balibrea E
Sci Rep; 2016 Apr; 6():24675. PubMed ID: 27091625
[TBL] [Abstract][Full Text] [Related]
4. Constitutive and treatment-induced CXCL8-signalling selectively modulates the efficacy of anti-metabolite therapeutics in metastatic prostate cancer.
Wilson C; Maxwell PJ; Longley DB; Wilson RH; Johnston PG; Waugh DJ
PLoS One; 2012; 7(5):e36545. PubMed ID: 22590561
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-8 signaling attenuates TRAIL- and chemotherapy-induced apoptosis through transcriptional regulation of c-FLIP in prostate cancer cells.
Wilson C; Wilson T; Johnston PG; Longley DB; Waugh DJ
Mol Cancer Ther; 2008 Sep; 7(9):2649-61. PubMed ID: 18790747
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma.
Maxwell PJ; Coulter J; Walker SM; McKechnie M; Neisen J; McCabe N; Kennedy RD; Salto-Tellez M; Albanese C; Waugh DJ
Eur Urol; 2013 Aug; 64(2):177-88. PubMed ID: 22939387
[TBL] [Abstract][Full Text] [Related]
7. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
Deeb D; Jiang H; Gao X; Al-Holou S; Danyluk AL; Dulchavsky SA; Gautam SC
J Pharmacol Exp Ther; 2007 May; 321(2):616-25. PubMed ID: 17289836
[TBL] [Abstract][Full Text] [Related]
8. Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs.
Singh RK; Lokeshwar BL
Mol Cancer; 2009 Jul; 8():57. PubMed ID: 19646263
[TBL] [Abstract][Full Text] [Related]
9. HIF-1 and NF-kappaB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells.
Maxwell PJ; Gallagher R; Seaton A; Wilson C; Scullin P; Pettigrew J; Stratford IJ; Williams KJ; Johnston PG; Waugh DJ
Oncogene; 2007 Nov; 26(52):7333-45. PubMed ID: 17533374
[TBL] [Abstract][Full Text] [Related]
10. Variable NF-κB pathway responses in colon cancer cells treated with chemotherapeutic drugs.
Samuel T; Fadlalla K; Gales DN; Putcha BD; Manne U
BMC Cancer; 2014 Aug; 14():599. PubMed ID: 25134433
[TBL] [Abstract][Full Text] [Related]
11. G31P, an antagonist against CXC chemokine receptors 1 and 2, inhibits growth of human prostate cancer cells in nude mice.
Liu X; Peng J; Sun W; Yang S; Deng G; Li F; Cheng JW; Gordon JR
Tohoku J Exp Med; 2012 Oct; 228(2):147-56. PubMed ID: 23019013
[TBL] [Abstract][Full Text] [Related]
12. Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells.
Yang J; Richmond A
Cancer Res; 2001 Jun; 61(12):4901-9. PubMed ID: 11406569
[TBL] [Abstract][Full Text] [Related]
13. Lunasin potentiates the effect of oxaliplatin preventing outgrowth of colon cancer metastasis, binds to α5β1 integrin and suppresses FAK/ERK/NF-κB signaling.
Dia VP; Gonzalez de Mejia E
Cancer Lett; 2011 Dec; 313(2):167-80. PubMed ID: 21963225
[TBL] [Abstract][Full Text] [Related]
14. Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.
Maxwell PJ; Neisen J; Messenger J; Waugh DJ
Oncotarget; 2014 Jul; 5(13):4895-908. PubMed ID: 24970800
[TBL] [Abstract][Full Text] [Related]
15. The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models.
Ning Y; Labonte MJ; Zhang W; Bohanes PO; Gerger A; Yang D; Benhaim L; Paez D; Rosenberg DO; Nagulapalli Venkata KC; Louie SG; Petasis NA; Ladner RD; Lenz HJ
Mol Cancer Ther; 2012 Jun; 11(6):1353-64. PubMed ID: 22391039
[TBL] [Abstract][Full Text] [Related]
16. Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
Jin F; Liu X; Zhou Z; Yue P; Lotan R; Khuri FR; Chung LW; Sun SY
Cancer Res; 2005 Jul; 65(14):6354-63. PubMed ID: 16024638
[TBL] [Abstract][Full Text] [Related]
17. Natural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaB.
Dai Y; Desano J; Tang W; Meng X; Meng Y; Burstein E; Lawrence TS; Xu L
PLoS One; 2010 Dec; 5(12):e14153. PubMed ID: 21170316
[TBL] [Abstract][Full Text] [Related]
18. The role of interleukin-8 (CXCL8) and CXCR2 in acquired chemoresistance of human colorectal carcinoma cells HCT116.
Dabkeviciene D; Jonusiene V; Zitkute V; Zalyte E; Grigaitis P; Kirveliene V; Sasnauskiene A
Med Oncol; 2015 Dec; 32(12):258. PubMed ID: 26519257
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting TNF-mediated signaling: a novel therapeutic paradigm for androgen independent prostate cancer.
Srinivasan S; Kumar R; Koduru S; Chandramouli A; Damodaran C
Apoptosis; 2010 Feb; 15(2):153-61. PubMed ID: 19851870
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation.
Seaton A; Scullin P; Maxwell PJ; Wilson C; Pettigrew J; Gallagher R; O'Sullivan JM; Johnston PG; Waugh DJ
Carcinogenesis; 2008 Jun; 29(6):1148-56. PubMed ID: 18487223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
